Citation
Tangpricha, V, et al. "An Update On the Screening, Diagnosis, Management, and Treatment of Vitamin D Deficiency in Individuals With Cystic Fibrosis: Evidence-based Recommendations From the Cystic Fibrosis Foundation." The Journal of Clinical Endocrinology and Metabolism, vol. 97, no. 4, 2012, pp. 1082-93.
Tangpricha V, Kelly A, Stephenson A, et al. An update on the screening, diagnosis, management, and treatment of vitamin D deficiency in individuals with cystic fibrosis: evidence-based recommendations from the Cystic Fibrosis Foundation. J Clin Endocrinol Metab. 2012;97(4):1082-93.
Tangpricha, V., Kelly, A., Stephenson, A., Maguiness, K., Enders, J., Robinson, K. A., Marshall, B. C., & Borowitz, D. (2012). An update on the screening, diagnosis, management, and treatment of vitamin D deficiency in individuals with cystic fibrosis: evidence-based recommendations from the Cystic Fibrosis Foundation. The Journal of Clinical Endocrinology and Metabolism, 97(4), 1082-93. https://doi.org/10.1210/jc.2011-3050
Tangpricha V, et al. An Update On the Screening, Diagnosis, Management, and Treatment of Vitamin D Deficiency in Individuals With Cystic Fibrosis: Evidence-based Recommendations From the Cystic Fibrosis Foundation. J Clin Endocrinol Metab. 2012;97(4):1082-93. PubMed PMID: 22399505.
TY - JOUR
T1 - An update on the screening, diagnosis, management, and treatment of vitamin D deficiency in individuals with cystic fibrosis: evidence-based recommendations from the Cystic Fibrosis Foundation.
AU - Tangpricha,V,
AU - Kelly,A,
AU - Stephenson,A,
AU - Maguiness,K,
AU - Enders,J,
AU - Robinson,K A,
AU - Marshall,B C,
AU - Borowitz,D,
AU - ,,
Y1 - 2012/03/07/
PY - 2012/3/9/entrez
PY - 2012/3/9/pubmed
PY - 2012/6/12/medline
SP - 1082
EP - 93
JF - The Journal of clinical endocrinology and metabolism
JO - J Clin Endocrinol Metab
VL - 97
IS - 4
N2 - OBJECTIVE: The objective was to develop evidence-based clinical care guidelines for the screening, diagnosis, management, and treatment of vitamin D deficiency in individuals with cystic fibrosis (CF). PARTICIPANTS: The guidelines committee was comprised of physicians, registered dietitians, a pharmacist, a nurse, a parent of an individual with CF, and a health scientist, all with experience in CF. PROCESS: Committee members developed questions specific to vitamin D health in individuals with CF. Systematic reviews were completed for each question. The committee reviewed and graded the available evidence and developed evidence-based recommendations and consensus recommendations when insufficient evidence was available. Each consensus recommendation was voted upon by an anonymous process. CONCLUSIONS: Vitamin D deficiency is common in CF. Given the limited evidence specific to CF, the committee provided consensus recommendations for most of the recommendations. The committee recommends yearly screening for vitamin D status, preferably at the end of winter, using the serum 25-hydroxyvitamin D measurement, with a minimal 25-hydroxyvitamin D concentration of 30 ng/ml (75 nmol/liter) considered vitamin D sufficient in individuals with CF. Recommendations for age-specific vitamin D intake for all individuals with CF, form of vitamin D, and a stepwise approach to increase vitamin D intake when optimal vitamin D status is not achieved are delineated.
SN - 1945-7197
UR - https://www.unboundmedicine.com/medline/citation/22399505/full_citation
L2 - https://academic.oup.com/jcem/article-lookup/doi/10.1210/jc.2011-3050
DB - PRIME
DP - Unbound Medicine
ER -
